BioCentury
ARTICLE | Company News

Shionogi, TB Alliance deal

June 17, 2013 7:00 AM UTC

Shionogi said it signed a memorandum of understanding with the alliance to screen new anti-tuberculosis drug candidates from Shionogi's compound library. Shionogi said the memorandum will focus on candidates against TB strains that are undermining TB global control efforts. The partners declined to disclose details. ...